-
10011248-10A benzimidazole analog that inhibits IKK-&epsilon with an IC50 value of ~15.8 µM.
-
10011248-25A benzimidazole analog that inhibits IKK-&epsilon with an IC50 value of ~15.8 µM.
-
10011248-5A benzimidazole analog that inhibits IKK-&epsilon with an IC50 value of ~15.8 µM.
-
10011249-1A benzimidazole analog that selectively inhibits IKK-&epsilon with an IC50 value of 40 nM and is essentially inactive at IKK-&alpha and IKK-&beta.
-
10011249-10A benzimidazole analog that selectively inhibits IKK-&epsilon with an IC50 value of 40 nM and is essentially inactive at IKK-&alpha and IKK-&beta.
-
10011249-5A benzimidazole analog that selectively inhibits IKK-&epsilon with an IC50 value of 40 nM and is essentially inactive at IKK-&alpha and IKK-&beta.
-
10011249-50A benzimidazole analog that selectively inhibits IKK-&epsilon with an IC50 value of 40 nM and is essentially inactive at IKK-&alpha and IKK-&beta.
-
10011256-1A CK2 inhibitor with an IC50 value of 0.8 µM.
-
10011256-10A CK2 inhibitor with an IC50 value of 0.8 µM.
-
10011256-5A CK2 inhibitor with an IC50 value of 0.8 µM.
-
10011256-50A CK2 inhibitor with an IC50 value of 0.8 µM.
-
10011264-1A potent and selective inhibitor of CK2 with an IC50 value of 0.3 µM and a Ki value of 0.2 µM.